{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T02:11:47Z","timestamp":1792721507993,"version":"4.5.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["J Cataract Refract Surg"],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:p>Moxifloxacin solution is frequently injected at the conclusion of cataract surgery for endophthalmitis prophylaxis. 2 different concentrations are most commonly available in the United States for intracameral (IC) use: 0.5% (5 mg\/mL) and 0.1% (1 mg\/mL). The recommended volume to be injected is different for the 2 concentrations, and incorrect dosing can increase the risk of toxic anterior segment syndrome or endophthalmitis. In addition, the U.S. Food and Drug Administration recently published an alert regarding potential adverse events associated with intraocular compounded moxifloxacin. This clinical advisory reviews the optimal dosing of IC moxifloxacin based on current evidence.<\/jats:p>","DOI":"10.1097\/j.jcrs.0000000000001237","type":"journal-article","created":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T20:00:10Z","timestamp":1686254410000},"page":"1068-1070","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["ASCRS clinical advisory on intracameral moxifloxacin injection for infection prophylaxis"],"prefix":"10.1097","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7873-861X","authenticated-orcid":false,"given":"William G.","family":"Myers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8103-3140","authenticated-orcid":false,"given":"David F.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7893-5805","authenticated-orcid":false,"given":"Neal H.","family":"Shorstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis S.","family":"Mah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Mamalis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5128-0685","authenticated-orcid":false,"given":"Kevin M.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the ASCRS Cataract Clinical Committee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-20250811","doi-asserted-by":"crossref","first-page":"P1","DOI":"10.1016\/j.ophtha.2021.10.006","article-title":"Cataract in the adult eye preferred practice pattern","volume":"129","author":"Miller","year":"2022","journal-title":"Ophthalmology"},{"key":"R3-20250811","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/j.jcrs.0000000000000757","article-title":"Antibiotic prophylaxis of postoperative endophthalmitis following cataract surgery: results of the 2021 ASCRS member survey","volume":"48","author":"Chang","year":"2022","journal-title":"J Cataract Refract Surg"},{"key":"R4-20250811","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1016\/j.jcrs.2007.07.009","article-title":"Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the 2007 ASCRS Member Survey","volume":"33","author":"Chang","year":"2007","journal-title":"J Cataract Refract Surg"},{"key":"R5-20250811","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.jcrs.2015.01.014","article-title":"Antibiotic prophylaxis of postoperative endophthalmitis following cataract surgery: results of the 2014 ASCRS Member Survey","volume":"41","author":"Chang","year":"2015","journal-title":"J Cataract Refract Surg"},{"key":"R6-20250811","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jcrs.2018.10.044","article-title":"Safety and efficacy of intracameral moxifloxacin for prevention of post-cataract endophthalmitis: randomized controlled clinical trial","volume":"45","author":"Melega","year":"2019","journal-title":"J Cataract Refract Surg"},{"key":"R7-20250811","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.jcrs.2019.04.018","article-title":"Endophthalmitis reduction with intracameral moxifloxacin in eyes with and without surgical complications: results from two-million consecutive cataract surgeries","volume":"45","author":"Haripriya","year":"2019","journal-title":"J Cataract Refract Surg"},{"key":"R8-20250811","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ophtha.2015.08.039","article-title":"Comparative effectiveness of antibiotic prophylaxis in cataract surgery","volume":"123","author":"Herrinton","year":"2016","journal-title":"Ophthalmology"},{"key":"R9-20250811","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jcrs.2006.09.019","article-title":"Safety of prophylactic intracameral moxifloxacin 0.5% ophthalmic solution in cataract surgery patients","volume":"33","author":"Espiritu","year":"2007","journal-title":"J Cataract Refract Surg"},{"key":"R10-20250811","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1136\/bjophthalmol-2017-311051","article-title":"Comparative analysis of the safety and efficacy of intracameral cefuroxime, moxifloxacin and vancomycin at the end of cataract surgery: a meta-analysis","volume":"102","author":"Bowen","year":"2018","journal-title":"Br J Ophthalmol"},{"key":"R11-20250811","doi-asserted-by":"crossref","first-page":"819","DOI":"10.4103\/ijo.IJO_1400_19","article-title":"Endophthalmitis prophylaxis study. Report 1: intracameral cefuroxime and moxifloxacin prophylaxis for the prevention of postcataract endophthalmitis in rural India","volume":"68","author":"Rathi","year":"2020","journal-title":"Indian J Ophthalmol"},{"key":"R12-20250811","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/aos.12684","article-title":"Antibiotic prevention of postcataract endophthalmitis: a systematic review and meta-analysis","volume":"93","author":"Kessel","year":"2015","journal-title":"Acta Ophthalmol"},{"key":"R14-20250811","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.ajo.2005.04.015","article-title":"Intracameral Vigamox (moxifloxacin 0.5%) is non-toxic and effective in preventing endophthalmitis in a rabbit model","volume":"140","author":"Kowalski","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"R15-20250811","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1016\/j.jcrs.2016.10.017","article-title":"Dose and administration of intracameral moxifloxacin for prophylaxis of postoperative endophthalmitis","volume":"42","author":"Arshinoff","year":"2016","journal-title":"J Cataract Refract Surg"},{"key":"R16-20250811","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1007\/s00417-013-2294-7","article-title":"Comparison between intracameral moxifloxacin administration methods by assessing intraocular concentrations and drug kinetics","volume":"251","author":"Matsuura","year":"2013","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R17-20250811","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.jcrs.2019.04.020","article-title":"Injection volume and intracameral moxifloxacin dose","volume":"45","author":"Shorstein","year":"2019","journal-title":"J Cataract Refract Surg"},{"key":"R18-20250811","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/j.jcrs.0000000000000064","article-title":"Comparative corneal endothelial cell toxicity of differing intracameral moxifloxacin doses after phacoemulsification","volume":"46","author":"Chang","year":"2020","journal-title":"J Cataract Refract Surg"},{"key":"R20-20250811","first-page":"1","article-title":"Toxic anterior segment syndrome with intracameral moxifloxacin: case report and review of the literature","volume":"2021","author":"Amireskandari","year":"2021","journal-title":"Case Rep Ophthal Med"},{"key":"R24-20250811","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.jcrs.2019.06.009","article-title":"Aqueous level abatement profiles of intracameral antibiotics: a comparative mathematical model of moxifloxacin, cefuroxime, and vancomycin with determination of relative efficacies","volume":"45","author":"Arshinoff","year":"2019","journal-title":"J Cataract Refract Surg"},{"key":"R25-20250811","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ajo.2021.02.007","article-title":"Endophthalmitis prophylaxis failures in patients injected with intracameral antibiotic during cataract surgery","volume":"227","author":"Shorstein","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"R26-20250811","doi-asserted-by":"crossref","first-page":"e00059","DOI":"10.1097\/j.jcro.0000000000000059","article-title":"Corneal decompensation following intrastromal hydration of corneal wounds with 0.5% moxifloxacin","volume":"9","author":"Fong","year":"2021","journal-title":"JCRS Online Case Rep"}],"container-title":["Journal of Cataract &amp; Refractive Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/j.jcrs.0000000000001237","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T21:01:03Z","timestamp":1754946063000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/j.jcrs.0000000000001237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":20,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/j.jcrs.0000000000001237","relation":{},"ISSN":["0886-3350","1873-4502"],"issn-type":[{"value":"0886-3350","type":"print"},{"value":"1873-4502","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"2023-03-01","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-05","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}